These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12403380)

  • 1. Synthetic factor VIIa concentrate to treat coagulopathy and gastrointestinal bleeding in an infant with end-stage liver disease.
    Tobias JD; Berkenbosch JW
    Clin Pediatr (Phila); 2002 Oct; 41(8):613-6. PubMed ID: 12403380
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of recombinant FVIIa for intraperitoneal coagulopathic bleeding in a septic patient.
    Holcomb JB; Neville HL; Fischer CF; Hoots K
    Curr Surg; 2003; 60(4):423-7. PubMed ID: 14972234
    [No Abstract]   [Full Text] [Related]  

  • 3. Combined fresh frozen plasma with recombinant factor VIIa in restoring hemostasis for invasive procedures in children with liver diseases.
    Chuansumrit A; Treepongkaruna S; Phuapradit P
    Thromb Haemost; 2001 Apr; 85(4):748-9. PubMed ID: 11341519
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of recombinant factor VIIa in liver diseases.
    Franchini M; Montagnana M; Targher G; Zaffanello M; Lippi G
    Blood Coagul Fibrinolysis; 2008 Jul; 19(5):341-8. PubMed ID: 18600080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Procedure for critical nonsurgical bleeding].
    Grottke O; Rossaint R
    Chirurg; 2007 Feb; 78(2):101-2, 104-9. PubMed ID: 17265055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating coagulopathy in liver disease with plasma transfusions or recombinant factor VIIa: an evidence-based review.
    Ramsey G
    Best Pract Res Clin Haematol; 2006; 19(1):113-26. PubMed ID: 16377545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage.
    Brady KM; Easley RB; Tobias JD
    Paediatr Anaesth; 2006 Oct; 16(10):1042-6. PubMed ID: 16972833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of acquired bleeding problems in cancer patients.
    DeLoughery TG
    Emerg Med Clin North Am; 2009 Aug; 27(3):423-44. PubMed ID: 19646646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy.
    Shami VM; Caldwell SH; Hespenheide EE; Arseneau KO; Bickston SJ; Macik BG
    Liver Transpl; 2003 Feb; 9(2):138-43. PubMed ID: 12548507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of recombinant factor VIIa in pediatric patients with liver failure and severe coagulopathy.
    Atkison PR; Jardine L; Williams S; Barr RM; Quan D; Wall W
    Transplant Proc; 2005 Mar; 37(2):1091-3. PubMed ID: 15848632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant factor VIIa for uncontrolled bleeding in 2 different cases of coagulopathy.
    Islam J; Azhar S; Alperin JB; Syed I
    J Am Board Fam Pract; 2003; 16(6):549-52. PubMed ID: 14963082
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of activated factor VII in severe acute hemorrhage].
    Milano Manso G; Rodríguez Amuedo F; Aragonés Manzanero R; Martínez Ferriz MC; Oliva Muñoz C; Calvo Macias C
    An Pediatr (Barc); 2005 May; 62(5):467-70. PubMed ID: 15871829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Management of hemostasis abnormalities in patients with liver failure].
    Ozier Y; Cadic A; Dovergne A
    Transfus Clin Biol; 2013 May; 20(2):249-54. PubMed ID: 23523600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of massive acute upper gastrointestinal bleeding in liver failure with activated recombinant factor VII (NovoSeven): a case report.
    Tonkic A; Jukic I; Titlic M; Mise S
    Blood Coagul Fibrinolysis; 2005 Jul; 16(5):385-7. PubMed ID: 15970725
    [No Abstract]   [Full Text] [Related]  

  • 15. [Upper gastrointestinal bleeding: medical aspects (author's transl)].
    Schuster HP
    Langenbecks Arch Chir; 1974; 337():511-8. PubMed ID: 4548735
    [No Abstract]   [Full Text] [Related]  

  • 16. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
    Yilmaz D; Karapinar B; Balkan C; Akisü M; Kavakli K
    Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulation management in massive bleeding.
    Griffee MJ; Deloughery TG; Thorborg PA
    Curr Opin Anaesthesiol; 2010 Apr; 23(2):263-8. PubMed ID: 20104172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant factor VIIa fails to correct coagulopathy induced by haemodilution with colloid.
    Sørensen B; Fenger-Eriksen C; Ingerslev J
    Br J Anaesth; 2005 Jun; 94(6):862-3. PubMed ID: 15878894
    [No Abstract]   [Full Text] [Related]  

  • 19. [Haemostaseological aspects of perioperative blood management].
    Scherer RU
    Zentralbl Chir; 2003 Jun; 128(6):473-80. PubMed ID: 12865952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant activated factor VII as an adjunctive therapy for bleeding control in severe trauma patients with coagulopathy: subgroup analysis from two randomized trials.
    Rizoli SB; Boffard KD; Riou B; Warren B; Iau P; Kluger Y; Rossaint R; Tillinger M;
    Crit Care; 2006; 10(6):R178. PubMed ID: 17184516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.